SCHEMBL5858029

SCHEMBL5858029

C/C(=C\C(=O)C(F)(F)F)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A1 P22736 1/20 0.51
▸ NR4A2 P43354 1/20 0.51
▸ NR4A3 Q92570 1/20 0.51
▸ CES1 P23141 3/20 0.50
▸ DEGS1 O15121 1/20 0.46
▸ MAPT P10636 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.42
▸ CES2 O00748 2/20 0.42
▸ CYP2C19 P33261 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ NFE2L2 Q16236 1/20 0.39
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5858034 1.00 NR4A1 (0.51) NR4A1NR4A2NR4A3CES1DEGS1
SCHEMBL5857387 0.83 MAPT (0.58) NR4A1NR4A2NR4A3CES1MAPT
SCHEMBL5857393 0.83 MAPT (0.58) NR4A1NR4A2NR4A3CES1MAPT
SCHEMBL10716767 0.81 DEGS1 (0.46) NR4A1NR4A2NR4A3CES1DEGS1
SCHEMBL15113893 0.80 NFE2L2 (0.57) CES1MAPTALDH1A1CES2CYP2C19
SCHEMBL691911 0.77 NR4A2 (0.60) NR4A1NR4A2NR4A3CES1DEGS1
SCHEMBL566351 0.77 DEGS1 (0.53) NR4A1NR4A2NR4A3CES1DEGS1
SCHEMBL566350 0.77 DEGS1 (0.53) NR4A1NR4A2NR4A3CES1DEGS1
SCHEMBL582234 0.77 NR4A2 (0.60) NR4A1NR4A2NR4A3CES1DEGS1
SCHEMBL1536443 0.77 NR4A2 (0.60) NR4A1NR4A2NR4A3CES1DEGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38963-E1 Pyrazoline derivatives, their preparation and application as medicaments LABORATORIOS DEL DR. ESTEVE (ES) 2006-01-31 — — US disclosed
EP-1083171-B1 PYRAZOLINE DERIVATIVES, THEIR PREPARATION AND APPLICATION AS MEDICAMENTS ESTEVE LABOR DR (ES) 2004-04-28 — — EP disclosed
US-6353117-B1 ANTIINFLAMMATORY ACTIVITY AND DISEASES IN WHICH CYCLOOXYGENASE-2 PLAYS A PART, WITHOUT HAVING THE GASTRIC AND RENAL TOXICITY OF THE CLASSIC NONSTEROIDAL ANTIINFLAMMATORY AGENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2002-03-05 — — US disclosed
EP-1083171-A1 PYRAZOLINE DERIVATIVES, THEIR PREPARATION AND APPLICATION AS MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2001-03-14 — — EP disclosed
Send feedback